Top List: The Top Drug Discovery & Development News of January 2015

Read this month’s top news stories about the latest technologies and techniques for Drug Discovery & Development.

Don’t Miss the SelectScience #MyPharmaVote at SLAS 2015!
SelectScience is delighted to announce the launch of the exclusive #MyPharmaVote poll at SLAS 2015. If you’re attending the show, visit the SelectScience booth #1308 to cast your vote on 12 of the best drug discovery and automation products.

Cord Blood Registry and Cellular Dynamics International Announce Collaboration to Reprogram Newborn Stem Cells into Induced Pluripotent Stem Cells
Cord Blood Registry® (CBR®) and Cellular Dynamics International have announced a research collaboration to reprogram newborn stem cells from both umbilical cord blood and umbilical cord tissue collected. The resulting induced pluripotent stem cells could be used by researchers in disease modeling, drug screening and in the early stages of cell-based therapy clinical trials.

Freeslate Integrates the DropSense96™ for Biologics Quantification on its Biologics Formulation System
Freeslate, Inc. and Trinean, NV., have announced the integration of the DropSense96™ with the CM3 product line for biotherapeutics formulation and optimization.

BMG LABTECH Celebrates 25 Years of Microplate Reader Innovation at SLAS 2015
BMG LABTECH, the Microplate Reader Company, will celebrate its 25th anniversary and introduce the new Atmospheric Control Unit to the US market at the SLAS conference 2015 in Washington, D.C.

Discover New Strategies for the Separation and Characterization of Protein Biopharmaceuticals
Register to watch the on-demand version of this free SelectScience webinar. Learn how advances in biochromatography are aiding the investigation of biopharmaceuticals.

How to Choose the Right GC Syringe for your Application
GC consumables play a vital role in an analytical laboratory. Discover how selecting the right GC syringe for your specific application enables fast, efficient analysis with a significant reduction in downtime.

Sigma-Aldrich® and VIB Form Alliance to Provide Scientists with Enhanced and Faster Access to Novel Translational Research Tools
Sigma-Aldrich Corporation’s Research business unit has formed an alliance with VIB, a leading life science research institute based in Flanders, Belgium, and focused on translational research in medical, agricultural and industrial applications. The alliance will concentrate on the commercialization and supply of new tools and technologies to help meet the evolving needs of translational researchers.